MANGOCEUTICALS, INC. Reports Unregistered Equity Sale
Ticker: MGRX · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities, dilution-risk
TL;DR
MANGOCEUTICALS sold unregistered stock, potential dilution incoming.
AI Summary
On March 28, 2025, MANGOCEUTICALS, INC. reported an unregistered sale of equity securities. The filing does not disclose specific details regarding the number of shares sold, the price per share, or the total dollar amount of the transaction.
Why It Matters
This filing indicates MANGOCEUTICALS, INC. has issued new equity outside of a public offering, which could impact existing shareholders through dilution.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes indicate a need for capital or a private placement that may not be as transparent as a public offering.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- March 28, 2025 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- Dallas (location) — Principal Executive Offices City
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities.
How many shares were sold in this unregistered offering?
The filing does not provide the number of shares sold.
What was the total dollar amount of the unregistered equity sale?
The filing does not disclose the total dollar amount of the transaction.
Who was the purchaser of these unregistered equity securities?
The filing does not identify the purchaser(s) of the unregistered equity securities.
What is the purpose of this unregistered sale of equity securities?
The filing does not state the specific purpose for the unregistered sale of equity securities.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding MANGOCEUTICALS, INC. (MGRX).